Collaboration Between CU Cancer Center and NantBioScience Targets Ral Protein
September 16, 2014 · Comments Off
Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs that target Ral protein activation, implicated in nearly a third of all cancers.
New Knowledge of Genes Driving Bladder Cancer Points to Targeted Treatments
September 15, 2014 · Comments Off
A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward defining the genetics of bladder cancer, and implies there may be at least two distinct genetic types of the disease.
Panel: Time is now for U.S. to lead in biomedical research
September 9, 2014 · Comments Off
The United States is in danger of losing its biomedical edge to countries that are...
Allen Lichter, CEO of ASCO, Says Big Data, Cost/Value and “-Omics” Will Dominate Oncology in 2030
September 4, 2014 · Comments Off
At the CU Cancer Center Fall Retreat 2014, Allen S. Lichter, MD, FASCO, CEO of ASCO, points the way toward the future of oncology in 2030
National Clinical Trial Tests Power of COXEN Model to Predict Best Treatment for Bladder Cancer
August 13, 2014 · Comments Off
COXEN, a computer model that suggests treatment based on cancer genetics, is being tested in a new clinical trial, here at the CU Cancer Center and nationally via clinical sites of the Southwest Oncology Research Group.
“Treatments Waiting to be Discovered” Inside New Database
August 5, 2014 · Comments Off
University of Colorado Cancer Center database, multiMiR, allows researchers to search microRNA, gene, disease, and drug interactions.
Whedon Cancer Detection Foundation grants $100k for bladder cancer research
August 1, 2014 · Comments Off
University of Colorado Cancer Center Director Dan Theodorescu, MD, PhD, recently received a $103,165 grant...
Major Genetic Study Links Liver Disease Gene to Bladder Cancer
April 4, 2014 · Comments Off
A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented tomorrow at the American Association for Cancer Research Annual Conference 2014) details the discovery of a new genetic driver of bladder cancer: silencing of the gene AGL.
Lung and bladder cancers have common cell-cycle biomarkers
January 29, 2014 · Comments Off
CU Cancer Center study: bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle.
Bitter melon juice prevents pancreatic cancer in mouse models
January 29, 2014
NTRK1: a new oncogene and target in lung cancer
January 29, 2014
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer clinical trials cancer grants cancer prevention cancer research colorado Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Have you liked us on FB yet? If not, be sure to do so for the latest updates on research, clinical trials, and events on.fb.me/1BRkDDh